Sanoculis

Private

IsraelHealthcare & Life Scienceshttps://sanoculis.com/

Last Round

Series C

Jul 28, 2022

Est. Valuation

$52M

Total Funding Raised

$26M

Company Overview

Sanoculis is an ophthalmic medical device company that develops innovative, stent-free, and minimally invasive surgical solutions for the treatment of glaucoma.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

glaucoma surgeryminimally invasive glaucoma surgeryMIGSstentless glaucoma surgeryophthalmic medical deviceintraocular pressure reductionsurgical drainage systemMIMSMINTeye surgery toolstrabeculectomy alternativesurgical trephinationophthalmology equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sanoculis Comparables

Compare Sanoculis with similar companies based on industry and business-model similarity.

Sanoculis comparables — related companies by embedding similarity
Company	Similarity	Market Cap
iSTAR Medical	82%
Sight Sciences	81%
ViaLase	80%

View all Comparables

Sanoculis Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Jul 28, 2022
Series B	Sep 11, 2019

View all Funding Rounds

Sanoculis Investors

Notable investors and investment history

Sanoculis investors
Investor	Rounds
Infinity Group	Series C
Eckuity	Series C
T3 Technion Technology Transfer	VC Round
HCS Capital Partners	Series B

View all Investors

Sanoculis Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Sanoculis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sanoculis's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael

Employee Range8

Year Founded2012

Last FundingJul 28, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?